166 related articles for article (PubMed ID: 11679846)
1. [Positron emission tomography in head and neck oncology: five cases].
Courtois A; Foehrenbach H; Maszelin P; De Dreuille O; Garcia D; Kossowski M; Merlet P; Gaillard JF; Poncet JL
Ann Otolaryngol Chir Cervicofac; 2001 Sep; 118(4):254-60. PubMed ID: 11679846
[TBL] [Abstract][Full Text] [Related]
2. Fluorine-18 fluorodeoxyglucose imaging using dual-head coincidence positron emission tomography without attenuation correction in patients with head and neck cancer.
Pai M; Park CH; Suh JH; Koh JH
Clin Nucl Med; 1999 Jul; 24(7):495-500. PubMed ID: 10402001
[TBL] [Abstract][Full Text] [Related]
3. Unknown primary detected by FDG-PET. A review of the present indications of FDG-PET in head and neck cancers.
Sheikholeslam-zadeh R; Choufani G; Goldman S; Hassid S
Acta Otorhinolaryngol Belg; 2002; 56(1):77-82. PubMed ID: 11894635
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of head and neck cancer with 18F-FDG PET: a comparison with conventional methods.
Kresnik E; Mikosch P; Gallowitsch HJ; Kogler D; Wiesser S; Heinisch M; Unterweger O; Raunik W; Kumnig G; Gomez I; Grünbacher G; Lind P
Eur J Nucl Med; 2001 Jul; 28(7):816-21. PubMed ID: 11504077
[TBL] [Abstract][Full Text] [Related]
5. Detection of unknown primary tumours and distant metastases in patients with cervical metastases: value of FDG-PET versus conventional modalities.
Regelink G; Brouwer J; de Bree R; Pruim J; van der Laan BF; Vaalburg W; Hoekstra OS; Comans EF; Vissink A; Leemans CR; Roodenburg JL
Eur J Nucl Med Mol Imaging; 2002 Aug; 29(8):1024-30. PubMed ID: 12173016
[TBL] [Abstract][Full Text] [Related]
6. Positron emission tomography with fluorodeoxyglucose for suspected head and neck tumor recurrence in the symptomatic patient.
Lonneux M; Lawson G; Ide C; Bausart R; Remacle M; Pauwels S
Laryngoscope; 2000 Sep; 110(9):1493-7. PubMed ID: 10983949
[TBL] [Abstract][Full Text] [Related]
7. [Results of pretherapeutic lymph node diagnosis in head and neck tumors. Clinical value of 18-FDG positron emission tomography (PET)].
Di Martino E; Nowak B; Krombach GA; Sellhaus B; Hausmann R; Cremerius U; Büll U; Westhofen M
Laryngorhinootologie; 2000 Apr; 79(4):201-6. PubMed ID: 10838683
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic evaluation of malignant head and neck cancer by F-18-FDG PET compared to CT/MRI.
Nowak B; Di Martino E; Jänicke S; Cremerius U; Adam G; Zimny M; Reinartz P; Büll U
Nuklearmedizin; 1999; 38(8):312-8. PubMed ID: 10615664
[TBL] [Abstract][Full Text] [Related]
9. Positron emission imaging of head and neck cancer, including thyroid carcinoma.
Schöder H; Yeung HW
Semin Nucl Med; 2004 Jul; 34(3):180-97. PubMed ID: 15202100
[TBL] [Abstract][Full Text] [Related]
10. Positron emission tomography for radiation treatment planning.
Grosu AL; Piert M; Weber WA; Jeremic B; Picchio M; Schratzenstaller U; Zimmermann FB; Schwaiger M; Molls M
Strahlenther Onkol; 2005 Aug; 181(8):483-99. PubMed ID: 16044216
[TBL] [Abstract][Full Text] [Related]
11. [Current status of nuclear medicine clinical application of FDG-PET for cancer diagnosis. Head and neck cancer].
Nakasone Y; Mogi K; Endo K
Nihon Igaku Hoshasen Gakkai Zasshi; 2002 May; 62(6):258-64. PubMed ID: 12073631
[TBL] [Abstract][Full Text] [Related]
12. [Is coincidence detection emission tomography (CDET) as reliable as positron emission tomography (PET) in head and neck cancer?].
Lazard DS; Baujat B; Barry B; Le Guludec D; Gehanno P
Rev Laryngol Otol Rhinol (Bord); 2003; 124(4):207-10. PubMed ID: 15038561
[TBL] [Abstract][Full Text] [Related]
13. [The integrated PET/CT: technological advance in diagnostics of head and neck recurrencies and CUP?].
Schneider K; Aschoff P; Bihl H; Hagen R
Laryngorhinootologie; 2006 Mar; 85(3):179-83. PubMed ID: 16547893
[TBL] [Abstract][Full Text] [Related]
14. Metastatic head and neck cancer: role and usefulness of FDG PET in locating occult primary tumors.
AAssar OS; Fischbein NJ; Caputo GR; Kaplan MJ; Price DC; Singer MI; Dillon WP; Hawkins RA
Radiology; 1999 Jan; 210(1):177-81. PubMed ID: 9885604
[TBL] [Abstract][Full Text] [Related]
15. [Correlation of FDG-PET and MRI/CT with histopathology in primary diagnosis, lymph node staging and diagnosis of recurrency of head and neck cancer].
Pöpperl G; Lang S; Dagdelen O; Jäger L; Tiling R; Hahn K; Tatsch K
Rofo; 2002 Jun; 174(6):714-20. PubMed ID: 12063600
[TBL] [Abstract][Full Text] [Related]
16. A comparative diagnostic study of head and neck nodal metastases using positron emission tomography.
McGuirt WF; Williams DW; Keyes JW; Greven KM; Watson NE; Geisinger KR; Cappellari JO
Laryngoscope; 1995 Apr; 105(4 Pt 1):373-5. PubMed ID: 7715380
[TBL] [Abstract][Full Text] [Related]
17. Impact of FDG-PET to detect recurrence of head and neck squamous cell carcinoma.
Périé S; Hugentobler A; Susini B; Balogova S; Grahek D; Kerrou K; Montravers F; Chater PE; St Guily JL; Talbot JN
Otolaryngol Head Neck Surg; 2007 Oct; 137(4):647-53. PubMed ID: 17903585
[TBL] [Abstract][Full Text] [Related]
18. Utility of combined (18)F-fluorodeoxyglucose-positron emission tomography and computed tomography in patients with cervical metastases from unknown primary tumors.
Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
Oral Oncol; 2009 Mar; 45(3):218-24. PubMed ID: 18804404
[TBL] [Abstract][Full Text] [Related]
19. A head and neck surgeon's perspective on best practices for the use of PET/CT scans for the diagnosis and treatment of head and neck cancers.
Funk GF
Arch Otolaryngol Head Neck Surg; 2012 Aug; 138(8):748-52. PubMed ID: 22911297
[No Abstract] [Full Text] [Related]
20. [Clinical evaluation of 18-fluorine fluorodeoxyglucose positron emission tomography-CT imaging in head and neck tumors].
Li XP; Liang Y; Liu X; Wang QS; Wu HB
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 May; 39(5):298-301. PubMed ID: 15338869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
